Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Advaccine, Akeso, Arcturus, Ascentage, Biogen, Biontech, Celltrion, Cytodyn, I-Mab, Innovent, Inovio, Junshi, Lion TCR, Luye, Novavax, Pfizer, Pharmamar, RDIF, Regeneron, Roche, Samsung Bioepis, Serum Life Sciences, Spero.